AOCI at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s AOCI?
- Trevi Therapeutics, Inc. (TRVI) reported AOCI of -$190K in Q1 2026.
- How has Trevi Therapeutics, Inc.'s AOCI changed year-over-year?
- Trevi Therapeutics, Inc.'s AOCI decreased by 360.3% year-over-year, from $73K to -$190K.
- What is the long-term trend for Trevi Therapeutics, Inc.'s AOCI?
- Over 3 years (2022 to 2025), Trevi Therapeutics, Inc.'s AOCI has grown at a 6.7% compound annual growth rate (CAGR), from -$122K to $148K.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.